title: Establishment of a novel anaplastic large-cell lymphoma-cell line (COST) from a 'small-cell variant' of ALCL.
abstract: Anaplastic large-cell lymphoma (ALCL) is a distinct biological and cytogenetic entity with a broad spectrum of morphological features (common type, small-cell variant and lymphohistiocytic variant). Few cell lines of ALCL are available and they all originate from primary tumors demonstrating the common type morphology (ie large-sized lymphoma cells). We established a new ALCL cell line (COST) from the peripheral blood of a patient with a small-cell variant of ALCL, at diagnosis. Cells growing in vitro and in SCID mice consisted of two populations, that is, small- and large-sized cells as seen in the patient's tumor. Both large and small malignant cells were positive for CD43/MT1 T-cell associated antigen, perforin, granzyme B and TIA-1, but negative for CD2, CD3, CD5, CD7, CD4 and CD8 antigens. Standard cytogenetic studies as well as multiplex FISH confirmed the presence of the canonical t(2;5)(p23;q35) translocation, but also revealed additional numerical and structural abnormalities. The COST cell line is the first ALCL small-cell variant cell line, and thus provides a potentially useful tool for further functional and molecular studies that should improve our understanding of the small-cell variant of ALCL, which is more frequently complicated by a leukemic phase.
authors.affiliation: Department of Oncogenesis and Signaling in Hematopoietic Cells, Inserm U-563, Centre de Physiopathologie de Toulouse-Purpan, Toulouse, France.
authors.forename: L
authors.initials: L
authors.lastname: Lamant
authors.forename: E
authors.initials: E
authors.lastname: Espinos
authors.forename: M
authors.initials: M
authors.lastname: Duplantier
authors.forename: N
authors.initials: N
authors.lastname: Dastugue
authors.forename: A
authors.initials: A
authors.lastname: Robert
authors.forename: M
authors.initials: M
authors.lastname: Allouche
authors.forename: J
authors.initials: J
authors.lastname: Ragab
authors.forename: P
authors.initials: P
authors.lastname: Brousset
authors.forename: C
authors.initials: C
authors.lastname: Villalva
authors.forename: R D
authors.initials: RD
authors.lastname: Gascoyne
authors.forename: T
authors.initials: T
authors.lastname: Al Saati
authors.forename: G
authors.initials: G
authors.lastname: Delsol
mesh_terms: D000818:Animals; D015703:Antigens, CD / Q000378:metabolism; D002675:Child, Preschool; D002869:Chromosome Aberrations; D002889:Chromosomes, Human, Pair 2 / Q000235:genetics; D002895:Chromosomes, Human, Pair 5 / Q000235:genetics; D020732:Cytogenetic Analysis; D005260:Female; D015329:Gene Rearrangement, T-Lymphocyte; D006801:Humans; D016130:Immunophenotyping; D017404:In Situ Hybridization, Fluorescence; D066298:In Vitro Techniques; D017728:Lymphoma, Large-Cell, Anaplastic / Q000235:genetics / Q000276:immunology / Q000473:pathology*; D008297:Male; D051379:Mice; D016513:Mice, SCID; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014178:Translocation, Genetic; D014407:Tumor Cells, Cultured
chemical_list: D015703:Antigens, CD